Subscribe   RSS Contact Us

Holcombe’s E&C Testimony: PDUFA VI Will Take Patient-focused Drug Development to New Level

March 23, 2017 – In testimony before the House Energy and Commerce Committee’s Subcommittee on Health yesterday, Biotechnology Industry Organization ... read more

Gottlieb Is “Known” Entity to Pharma Industry

March 20, 2017 – Although medical marketers are very familiar with Scott Gottlieb, President Donald Trump’s choice for the top ... read more

Industry Groups Oppose Oregon Bill Calling for Advertising Price Disclosure

March 9, 2017 – Four major advertising and media industry groups have issued a joint letter opposing an Oregon bill ... read more

Trump Needs to Take a Closer Look at FDA Performance

March 8, 2017 – In an open letter to President Donald Trump, Pharmalot’s Ed Silverman asks that before Trump criticizes ... read more

Industry Peacekeeping with President Trump Holds Promise But Portends Danger

By John Kamp, Executive Director, Coalition for Healthcare Communication [Editor’s Note: This “The Final Word” column appeared in the February ... read more

Citizen Petition Calls on FDA to Stay Final Rule Establishing “Totality of the Evidence” Standard for Intended Use

Feb. 24, 2017 – The FDA recently published a final rule on intended use and adequate directions for use that ... read more

Previous Next

The Debate Over Increased Transparency

From Tom Sullivan’s Policy and Medicine blog, July 16, 2010:

As drug companies “prepare for new draconian provisions for reporting on financial relationships with prednisone vs hydrocodone academia,” a recent article in Nature Biotechnology investigated whether such efforts to “increase transparency will prove burdensome to researchers and the industry.”

The inquiry stems from “the latest fallout from Senator Charles Grassley’s (R-IA) campaign for increased transparency between physician researchers and industry.” This campaign has included numerous letters and investigations involving doctors, organizations and associations, agencies (e.g. NIH), medical journals, and drug and device companies.

Read more on their website, then come back here to comment.generic viagra soft tabs

Comments are closed.